180 related articles for article (PubMed ID: 31819366)
1. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
[TBL] [Abstract][Full Text] [Related]
2. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
3. The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells.
Ren C; Gao C; Li X; Xiong J; Shen H; Wang L; Zhu D; Wu P; Ding W; Wang H
Anticancer Agents Med Chem; 2020; 20(17):2125-2135. PubMed ID: 32753022
[TBL] [Abstract][Full Text] [Related]
4. Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells.
Xu W; Xie S; Chen X; Pan S; Qian H; Zhu X
Drug Des Devel Ther; 2021; 15():577-588. PubMed ID: 33623367
[TBL] [Abstract][Full Text] [Related]
5. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
[TBL] [Abstract][Full Text] [Related]
6. Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins.
Lin M; Pan C; Xu W; Li J; Zhu X
Drug Des Devel Ther; 2020; 14():1885-1895. PubMed ID: 32523334
[TBL] [Abstract][Full Text] [Related]
7. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
8. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells.
Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
[TBL] [Abstract][Full Text] [Related]
9. Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells.
Li X; Zhao J; Yan T; Mu J; Lin Y; Chen J; Deng H; Meng X
J Food Sci; 2021 Jun; 86(6):2700-2712. PubMed ID: 33908630
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between the expression of P-glycoprotein, glutathione S-transferase-pi and thymidylate synthase proteins and adenosine triphosphate tumor chemosensitivity assay in cervical cancer].
Gao GL; Wan HY; Zou XS; Chen WX; Chen YQ; Huang XZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):201-5. PubMed ID: 17537309
[TBL] [Abstract][Full Text] [Related]
11. [EBF1 Promotes the Sensitivity of Cervical Cancer Cells to Cisplatin via Activating FBN1 Transcription].
Shen NN; Lin JH; Liu PP
Mol Biol (Mosk); 2023; 57(3):503-504. PubMed ID: 37326054
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Novel α-Methylchalcone Derivatives, Anti-Cervical Cancer Activity, and Reversal of Drug Resistance in HeLa/DDP Cells.
Yang Z; Liu Z; Ablise M; Maimaiti A; Aihaiti A; Alimujiang Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067428
[TBL] [Abstract][Full Text] [Related]
13. The effects of combined treatment with sevoflurane and cisplatin on growth and invasion of human adenocarcinoma cell line A549.
Liang H; Wang HB; Liu HZ; Wen XJ; Zhou QL; Yang CX
Biomed Pharmacother; 2013 Jul; 67(6):503-9. PubMed ID: 23639227
[TBL] [Abstract][Full Text] [Related]
14. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anticancer activity of 5-aminolevulinic acid photodynamic therapy in combination with low-dose cisplatin on Hela cells.
Wei XQ; Ma HQ; Liu AH; Zhang YZ
Asian Pac J Cancer Prev; 2013; 14(5):3023-8. PubMed ID: 23803073
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Derived Exosomal miR-651 as a Diagnostic Marker Restrains Cisplatin Resistance and Directly Targets ATG3 for Cervical Cancer.
Zhu X; Long L; Xiao H; He X
Dis Markers; 2021; 2021():1544784. PubMed ID: 34567283
[TBL] [Abstract][Full Text] [Related]
17. Clinically relevant concentration of sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways.
Ding J; Zhang L; Zeng S; Feng T
Biochem Biophys Res Commun; 2019 Jul; 514(4):1179-1184. PubMed ID: 31103261
[TBL] [Abstract][Full Text] [Related]
18. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
Duan W; Liu X
Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
[TBL] [Abstract][Full Text] [Related]
19. Kynureninase knockdown inhibits cisplatin resistance in vivo and in vitro and impacts the prognosis of cervical adenocarcinoma.
Zhang JW; Wang YN; Zhong ML; Liang MR
Cell Div; 2023 Sep; 18(1):15. PubMed ID: 37742026
[TBL] [Abstract][Full Text] [Related]
20. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
[No Abstract] [Full Text] [Related]
[Next] [New Search]